*For more information Send Email

Moderator: Marc Steben

09:00 - 09:20 Introductions - Marc Steben

09:00 - 10:30 “Speed Intros”

10:30 - 10:45 Coffee Break

10:45 - 11:45 Finding Funding:
Canada: Scott Gray-Owen
USA: Julie Dombrowski
Industry:
Ajith Joseph, Abbott
Courtney Maus, BD
Anu Rebbapragada, Hologic
Chris McGowin, Roche

11:45 - 13:00 Lunch / Career Panel
Chris L. McGowin, Max Chernesky (TBC), Petra Smyczek

13:00 - 14:00 Manuscript Workshop - Bill Miller

14:00 - 15:00 Small Group Discussions
• Work-life balance and avoiding burnout: Abigail Norris-Turner
• How to grow your network/increase visibility: Max Chernesky (TBC)
• Thorny issues in collaboration: Julie Dombrowski
• Balancing clinical, research and teaching: Irene Martin (TBC)
• Community engagement, health departments & advisory boards: Marc Steben

15:00 - 15:30 Conclusion and Next Steps

Organized by Sevgi Aral and James Blanchard

Chair: James Blanchard, University of Manitoba, Canada

09:00 - 09:05 Welcome and Introductions

09:05 - 09:35 STI/HIV prevention today
- Sevgi Aral, Centers for Disease Control and Prevention, USA

09:35 - 10:05 Background and progress in phase-specific strategies
- Judy Wasserheit, University of Washington, USA 

10:05 - 10:35 Emerging research methods and collaborations to improve program design and implementation
- Geoff Garnett, Bill & Melinda Gates Foundation, USA

11:00 - 11:30 Appraising epidemic phases and transmission dynamics – insights from epidemiology and mathematical modeling
- Sharmistha Mishra, St. Michael's Hospital, Canada

11:30 - 12:00 Art-based prevention: Observations on the pathway from efficacy to effectiveness
- Myron Cohen, University of North Carolina, USA

12:00 - 12:30 Round Table Discussion – What have we learned from modeling about targeting for HIV prevention, and what more do we need to learn?
Moderator: Sevgi Aral, Centers for Disease Control and Prevention, USA
• Geoff Garnett
• Sharmistha Mishra
• Judy Wasserheit
• Myron Cohen

Chair: Stephen Moses, University of Manitoba, Canada

13:30 - 14:00 How can we improve resource allocation and management in the changing global HIV landscape?
- David Wilson, World Bank, USA

14:00 - 14:30 HIV and STI prevention program design: Back to the basics
- James Blanchard, University of Manitoba, Canada

14:45 - 15:15 Challenges in the implementation of new interventions for HIV/STI
- Helen Ward, Imperial College London, UK

15:15 - 15:45 Phase shifts in HIV and STI epidemics in Sub-Saharan Africa: Implications for programs and science
- Richard Hayes, London School of Hygiene & Tropical Medicine, UK

15:45 - 16:15 Round Table Discussion – Phase Specific Strategies and future priorities for Program Science
Moderator: Marissa Becker, University of Manitoba, Canada
• David Wilson
• Helen Ward
• James Blanchard
• Richard Hayes

16:15 - 16:30 Wrap-up – Concluding Remarks
- Sevgi Aral, Centers for Disease Control and Prevention, USA

Organized by University of California Los Angeles

08:00 - 08:10 Welcome
- Jackie McDowell, Cepheid

08:10 - 08:30 Overview
- Jeffrey D Klausner, University of California, Los Angeles, USA

08:30 - 08:55 Curable STIs in pregnant women living in Brazil; A challenge ripe for intervention
- Nava Yeganeh, University of California, Los Angeles, USA

08:55 – 09:20 Syndromic management for STIs during pregnancy just doesn't cut it anymore: Implementing diagnostic screening to reduce adverse birth outcomes in South Africa
- Andrew Medina-Marino, Foundation of Professional Development, South Africa

09:20 - 09:45 Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-income settings: the WANTAIM Trial, Papua New Guinea
- Andrew Vallely, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea & The Kirby Institute, UNSW Sydney, Australia

09:45 - 10:10 Antenatal Chlamydia trachomatis and Neisseria gonorrhoeae testing compared to syndromic management in Botswana: A cost-effectiveness study
- Adriane Wynn, University of California, San Diego, USA

10:10 - 10:20 Break

10:20 - 10:45 Chlamydia trachomatis screening and treatment among pregnant women in China: Evidence and challenges
- Weiming Tang, University of North Carolina at Chapel Hill, USA

10:45 - 11:10 The ASPIRE Trial – aiming for safe pregnancies: Reducing malaria and infections of the reproductive tract in Zambia
- Matthew Chico, London School of Hygiene & Tropical Medicine, United Kingdom

11:10 - 11:35 Enhancing nutrition and antenatal infection treatment for maternal and child health (ENAT) study: Screening and treating genitourinary tract infections to improve birth outcomes in Amhara, Ethiopia
- Rose L. Molina, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

11:35 - 12:00 Summary and next steps
- Nicola Low, Institute of Social and Preventive Medicine, University of Bern, Switzerland

Organized by Jen Balkus

Speaker(s):

08:00 - 08:15 Introductions and motivations for the Vaginal Microbiome Laboratory Variability Project (MLVP)
- Jen Balkus, University of Washington, USA

08:15 - 08:30 Overview of the Vaginal Microbiome Laboratory Variability Project
- David Fredricks, Fred Hutchinson Cancer Research Center, USA

08:30 - 09:00 Laboratory challenges and opportunities to reduce variability: Lessons learned from the MLVP
- Sujatha Srinivasan, Fred Hutchinson Cancer Research Center, USA & Darrell Dinwiddie, University of New Mexico, USA

09:00 - 09:30 Bioinformatics challenges and opportunities to reduce variability: Lessons learned from the MLVP
- Johanna Holm, University of Maryland & Liam Van Der Pol, University of Alabama, USA

09:30 - 10:00 Coffee break

10:00 - 10:20 Statistical analyses and challenges for assessing variability
- Jim Hughes, University of Washington, USA & Pawel Gajer, University of Maryland, USA

10:20 - 10:40 Successes and challenges of implementing the MLVP and opportunities to improve reproducibility moving forward
- Jacques Ravel, University of Maryland, USA

10:40 - 11:20 Round table discussion with other experts engaged in vaginal microbiome research

Panel discussion with

- Carolyn Deal (NIAID/DMID)

- Jennifer Fettweis (VCU)

- Doug Kwon (Ragon Institute)

- Deborah Money (UBC)

11:20 - 11:30 Wrap-up
- Jen Balkus, University of Washington, USA

Organized by Arlene C. Seña

Facilitators:

Laura Bachmann, MD, MPH - Medical Director, CDC Division of STD Prevention
Christine Johnson, MD, MPH - Associate Professor, University of Washington at Seattle; Medical Director, University of Washington STD Prevention Training Centers

Speaker(s):

Talk 1. Global STI trends and priorities for antimicrobial resistance
- Teodora Elvira Wi, MD
Medical Officer, STI Department of Reproductive Health and Research, World Health Organization

Talk 2. Pharmacokinetics and pharmacodynamics – factors to consider for STI treatment
- Jane Hocking, MD
Professor, Centre for Epidemiology and Biostatistics, Melbourne, Melbourne School of Population and Global Health, University of Melbourne

Talk 3. Resistance emergence: Single vs combination therapies
- George L. Drusano, MD
Professor and Director, Institute for Therapeutic Innovation, University of Florida

Talk 4. Molecular tests for prediction of antimicrobial resistance (or susceptibility) in N. gonorrhoeae and M. genitalium
- Magnus Unemo, PhD
Associate Professor, Director, WHO Collaborating Centre for gonorrhoea and other STIs, Swedish Reference Laboratory for STIs, Örebro University Hospital, Sweden

Talk 5. Are we ready for this? - Antimicrobial stewardship for STIs
- Arlene C. Seña, MD, MPH
Associate Professor, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill; Medical Director, Durham County Department of Public Health

 

Organized by David Lewis and Gwenda Hughes

Refreshments supported by Western Sydney Sexual Health, University of Sydney, Australia

Speaker(s):

Talk 1. Syphilis: A historical overview
- David Lewis, University of Sydney, Australia

Talk 2. Keynote Lecture: Syphilis pathogenesis: What we know and what we need to know
- Sheila Lukehart, University of Washington, USA

Talk 3. The application of modern technologies to the goal of syphilis elimination
- Caroline Cameron, University of Victoria, Canada

Talk 4. What can we learn about syphilis from whole genome sequencing of global Treponema pallidum strains
- Nick Thomson, Sanger Institute, UK

Talk 5. Syphilis in the context of HIV co-infection
- Khalil Ghanem, Johns Hopkins University, USA

Talk 6. Syphilis, the great imitator: Unusual case presentations of syphilis in adults
- Somesh Gupta, All India Institute of Medical Sciences, India

Talk 7. Recent trends in syphilis in women and congenital syphilis in developed countries: A changing epidemiology?
- Gwenda Hughes, Public Health England, UK

Talk 8. Drivers and determinants for the rising incidence of syphilis in men-who-have-sex-with-men
- Kyle Bernstein, Centers for Disease Control and Prevention, USA

Talk 9. Responding to syphilis in China: The importance of key populations
- Xiang-Sheng Chen, National Center for STD Control, China

Organized by Igor Toskin

PART I - SRH behavioural interventions Global State of Affairs

Co-chairs: Igor Toskin, World Health Organization, Switzerland - King Holmes, Dept. of Global Health & Medicine, University of Washington, USA - Carmen Logie, University of Toronto, Canada

Talk 1. WHO perspective on behavioural interventions
- Igor Toskin, World Health Organization, Switzerland

Talk 2. Exploring the landscape of behavioural HIV/STI prevention interventions in Canada
- Carmen Logie, University of Toronto, Canada

Talk 3. Scientific evidence of effectiveness of behavioural interventions for shifting sexual health outcomes
- Rob Stephenson, Center for Sexuality and Health Disparities, University of Michigan, USA

Talk 4. Delivering behavioural interventions through e-health and mHealth technologies
- Keith Horvath, University of Minnesota, USA

Talk 5. Screening of a behavioural intervention using Motivational Interviewing (MI)

PART II - Country perspectives behavioural interventions and WHO Brief Sexuality-related Communication (BSC) feasibility study

Co-chairs: Igor Toskin, World Health Organization, Switzerland - Carmen Logie, University of Toronto, Canada

Talk 6. MI in France
- Experiences and results of MI-training for pharmacists
- MI-training for counsellors of an HIV phone-service, 'SIDA-infoservice'
- Thierry Troussier, Chaire UNESCO Santé sexuelle et Droits humains, Paris, France

Talk 7. Introduction of the WHO BSC feasibility study
- Sofia de Vasconcelos, World Health Organization, Switzerland

Talk 8. WHO BSC feasibility study in Peru: Results of the formative phase and next steps
- Carlos Caceres, Universidad Peruana Cayetano Heredi, Peru

Talk 9. WHO BSC feasibility study in Moldova: Populations and objectives
- Natalia Bakunina, World Health Organization, Switzerland /Larisa Boderscova, WHO, Moldova

Talk 10. Behavioural intervention showcase (video)
- youth counselling
- M-health intervention
- BSC training video Peru

Organized by Valeria Stuardo Ávila

Speaker(s):

Talk 1. The Ibero-American network on gay men, others MSM and trans studies (RIGHT)
- Valeria Stuardo Ávila, Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Santiago, Chile

Talk 2. The methodological framework of Latin American men who have sex with men internet survey (LAMIS) in light of the prior EMIS studies
- Ulrich Marcus, Robert Koch Institute, Berlin, Germany

Talk 3. Implementation of LAMIS as a collaborative effort in Latin American countries
- Carlos Cáceres, Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru

Talk 4. General results - descriptive analysis of LAMIS 2018: Implications for collaborative public policies in the Latin American region
- Jordi Casabona, Centre d'EstudisEpidemiològics sobrelesInfeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Barcelona, Spain

Talk 5. HIV among MSM and TGW in Brazil: Different approaches, same striking results
- Maria Amélia Veras, Faculdade de Ciências Médicas daSanta Casa de São Paulo, Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT, Brazil

 

Organized by Okeoma Mmeje

Speaker(s):

Talk 1. Overview of expedited partner therapy
- Okeoma Mmeje, University of Michigan, USA

Talk 2. Expedited partner therapy use in heterosexuals
- Jenell Coleman, Johns Hopkins University, USA

Talk 3. Expedited partner therapy use in adolescents & school-based clinics
- Nicole Speck, University of Michigan, USA

Talk 4. Support for expedited partner therapy use in men who have sex with men & transgender women
- Kristi Gamarel, University of Michigan, USA
- Raha Richardson, University of Michigan, USA

Talk 5. Implications for expedited partner therapy use in men who have sex with men
- Julia Schillinger, Centers for Disease Control and Prevention, USA

 

Organized by Ameeta Singh

Chair(s):

Max Chernesky, McMaster University, Canada
Margaret Gale-Rowe, PHAC, Canada

Speaker(s):

Talk 1. Mycoplasma genitalium
- Annie-Claude Labbe, Université de Montréal, Canada

Talk 2. Gonorrhea: Approach to management in the setting of rising antimicrobial resistance
- Ameeta Singh, University of Alberta, Canada

Talk 3. Prenatal screening for STBBIs
- Mark Yudin, University of Toronto, Canada

Organized by Jo-Anne Dillon, President, IUSTI Canada

Speaker(s):

Talk 1. International dissemination of ceftriaxone-resistant Neisseria gonorrhoeae strain (FC428)
- Petra Smyczek, Alberta Health Services, Edmonton, Alberta, Canada

Talk 2. What’s new in gonococcal antimicrobial resistance and diagnosis of AMR
- Jo-Anne Dillon, Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, Canada

Talk 3. New anti-gonococcal antibiotics, discovery and pipeline
- Gerry Wright, McMaster University, Hamilton, Ontario, Canada

Talk 4. Almost Human: Advanced preclinical models for gonococcal vaccine and drug development
- Scott Gray-Owen, University of Toronto, Toronto, Ontario, Canada

Organized by Leonard Foster

Speakers:

Talk 1. Metaproteomics for discovering mechanisms and biomarkers in the vaginal microbiome
- Adam Burgener, University of Manitoba, Canada

Talk 2. Towards the development of a SISCAPA assay for direct measurement of T. pallidum proteins in bodily fluids
- Morty Razavi, SISCAPA Assay Technologies (SAT), Canada

Talk 3. When and how to bring in proteomics
- Leonard Foster, UBC, Canada

Talk 4. Practical considerations for moving proteomic tests into the clinic
- Angela Fung, Clinical Chemist, St. Paul’s Hospital, Vancouver, Canada

Organized by the Sexually Transmitted Infections Vaccine Consortium, based in British Columbia (STRIVE-BC)

Speaker(s):

Opening remarks
- Troy Grennan, University of British Columbia & the BC Centre for Disease Control, Canada

Talk 1. The current landscape of STI vaccines
- Carolyn Deal, National Institute of Allergy and Infectious Diseases, USA

Talk 2. STI vaccine roadmap
- Sami Gottlieb, World Health Organization, Switzerland

Talk 3. Will the world accept STI vaccines? Lessons from the HPV vaccine
- Simon Dobson, University of British Columbia, Canada

Talk 4. STI vaccine Development updates: Current science and future directions
- Syphilis: Caroline Cameron, University of Victoria, Canada
- Gonorrhea: Rino Rappuoli, GSK Vaccines, Italy
- Chlamydia: Kevin Hybiske, University of Washington, USA
- HSV: Anna Wald, University of Washington, USA

Talk 5. Priority setting for future science & research (panel discussion) 
- Moderated by: Scott Lamontagne, University of Washington, USA
- Caroline Cameron, University of Victoria, Canada
- Carolyn Deal, National Institute of Allergy and Infectious Diseases, USA
- Charu Kaushic, Canadian Institutes of Health Research, Canada
- Rino Rappuoli, GSK Vaccines, Italy
- Peter Dull, Bill & Melinda Gates Foundation

Talk 6. Implementation challenges in public health (panel discussion) 
- Moderated by: Scott Lamontagne, University of Washington, USA
- Sami Gottlieb, World Health Organization, Switzerland
- Bonnie Henry, Government of British Columbia, Canada
- Manish Sadarangani, Vaccine Evaluation Center, Canada
- Peter Dull, Bill & Melinda Gates Foundation

Closing remarks
- Manish Sadarangani, Vaccine Evaluation Centre, Canada and Gina Ogilvie, School of Population and Public Health (SPPH), Canada

Organized by Igor Toskin

PART I - STI POCT Global State of Affairs

Co-chairs: Igor Toskin, World Health Organization, Switzerland and Rosanna Peeling, London School of Hygiene and Tropical Medicine, United Kingdom

Talk 1. WHO Initiative on STI POCT: vision, progress and way forward
- Igor Toskin, World Health Organization, Switzerland

Talk 2. Epidemiology of gonococcal infections in infertile populations: Systematic review and meta-analytics
- Hiam S. Chemaitelly, Weill Cornell Medical College, Qatar

Talk 3. POC diagnostic tests and technologies for sexually transmitted infections: A landscape analysis
- Maurine Murtagh, World Health Organization, Switzerland

Talk 4. Policy development and Implementation successes and challenges in introducing STI POCTs
- Rosanna Peeling, London School of Hygiene and Tropical Medicine, United Kingdom

Talk 5. Rapid AMR-test technology to enable immediate accurate treatment and enhance AMR surveillance
- Tariq Sadiq, St George's University of London, United Kingdom

Talk 6. Sample self-collection and STI self-testing
- Ellen Kersh, Centers for Disease Control and Prevention (CDC), Atlanta, USA

PART II - Country Perspective and Current WHO STI POCT Evaluation Studies

Co-chairs:
Ranmini Kularatne, Centre for HIV & STIs, National Institute for Communicable Diseases, Johannesburg, South Africa and Ron Ballard, World Health Organization, Switzerland

Talk 7. Independent multi-country clinic-based evaluation of STI POCTs: study design, methodology, research instruments, data management system and current status
- Soe Soe Thwin, World Health Organization, Switzerland
- Massimo Mirandola, University of Verona, UoV, Italy
- Karel Blondeel, World Health Organization, Switzerland

Talk 8. Independent multi-country clinic-based evaluation of STI POCTs: internal quality control and external quality assurance:
- NG/CT/TV - Ellen Kersh, Centers for Disease Control and Prevention (CDC), Atlanta, USA
- HIV/syphilis - Kelly Andrewartha, Flinders University, Adelaide, Australia

Talk 9. Independent multi-country clinic-based evaluation of STI POCTs, implementation in selected sites:
- Italy: challenges and opportunities in piloting the study procedures and engaging with MSM in an outpatient setting - Maddalena Cordioli, University of Verona, UoV, Italy

- South Africa: current status, programmatic needs and challenges - Ranmini Kularatne, Centre for HIV & STIs, National Institute for Communicable Diseases, Johannesburg, South Africa

- Peru - Carlos Cáceres, Universidad Peruana Cayetano Heredia, Peru

Talk 10. Independent multi-country clinic-utility evaluation of STI diagnostics: study design, methodology, research instruments, data management system and current status
- Jordi Casabona, Centre d’Estudis Epidemiològics sobre les ITS i Sida de Catalunya, CEEISCAT, Spain

Workshop organising committee:

Dr Katy Turner, Prof Nicola Low, Dr Yonatan Grad, Prof Teodora Wi, Prof Magnus Unemo, Dr Minttu Ronn

The workshop will provide a cross-disciplinary approach to the challenge of antimicrobial resistant (AMR) bacteria causing sexually transmitted infections (STIs). Antimicrobial resistance is a complex challenge, most of the data and published work is focused on high income settings, but the main burden of disease due to drug resistance will occur in low and middle income (LMIC) countries. Please tweet from the workshop using the following hashtags.

#AMRSTI #ISSTDR2019 #IUSTIWorld2019

Speaker(s):

13:00 Session 1 - setting the scene

WHO perspectives on the threat of AMR – global challenges of surveillance
- Prof Teodora Wi

Antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium
- Prof Magnus Unemo

Epidemiological trends in Neisseria gonorrhoeae and implications for services
- Prof Nicola Low

13:15 Panel discussion

13:45 Quantifying the surveillance needed to sustain genetic marker-based antibiotic resistance diagnostics
- Prof Yonatan Grad

13:50 Modelling evolution of resistance over time in N. gonorrhoeae
- Dr Lilith Whittles

14:00 Modelling the impact of resistance on gonorrhoea epidemiology
- Dr Katy Turner

14:30 Session 2 - Global perspective

14:30 Modelling vaccination as a way to control AMR
- Dr Laith Abu Raddad

14:45 Impact of vaccination on the sustainable transmission of Neisseria gonorrhoeae drug-resistant strains
- Dr Shaheen Seedat

14:55 The Brazilian public health policy for gonorrhea
- Dr Pâmela Cristina Gaspar

15:10 Gonorrhea in the era of AMR, diagnostic needs for improved antimicrobial stewardship in low and middle income countries
- Dr Cecilia Ferreyra

15:25 Panel discussion

Organized by Dr Louise Jackson

Coffee & networking

13:00 - 13:15 The economics of sexual health services and interventions – a service perspective
Professor Jonathan Ross

13:15 - 14:00 Overview of key principles in analysing costs and benefits in Sexual Health
Professor Tracy Roberts

14:00 - 14:45 A practical guide to collecting and analysing data on costs and benefits
Dr Louise Jackson

14:45 – 15:00 Break (coffee & networking)

15:00 - 16:00 Activity – analysing an economic study

16:00 - 16:40 Workshop – developing an evaluation

16:40 - 17:00 Synthesis & next steps
Professor Jonathan Ross & Professor Tracy Roberts

Organized by Lisa McDaid

Chair(s): 

Lisa McDaid, University of Glasgow, UK

Speaker(s): 

Talk 1. Introduction to contemporary behavioural surveillance
- Lisa McDaid, University of Glasgow, UK
- Nathan Lachowsky, University of Victoria, Canada

Talk 2. The current state of behavioural surveillance (panel discussion) 
- Nathan Lachowsky, University of Victoria, Canada
- Patrick Sullivan, Emory University, USA
- Benjamin Bavinton, Kirby Institute, Australia
- Peter Saxton, University of Auckland, New Zealand
- Jamie Frankis, Glasgow Caledonian University, UK

Talk 3. Changing HIV epidemics and representativeness of behavioural surveillance research (panel discussion) 
- Peter Saxton, University of Auckland, New Zealand
- Nathan Lachowsky, University of Victoria, Canada
- Jamie Frankis, Glasgow Caledonian University, UK

Talk 4. Why do we still need behavioural surveillance in the age of biomedical HIV prevention? (panel discussion) 
- Benjamin Bavinton, Kirby Institute, Australia
- Jamie Frankis, Glasgow Caledonian University, UK
- Patrick Sullivan, Emory University, USA

Talk 5. Neglected populations and regions (panel discussion) 
- Jacqueline Gahagan, Dalhousie University, Canada
- Tyrone Curtis, University College London, UK
- Harlan Pruden, BC Centre for Disease Control, Canada

Talk 6. Biobehavioural surveillance: The challenges of biological sampling (panel discussion) 
- Patrick Sullivan, Emory University, USA
- Jamie Frankis, Glasgow Caledonian University, UK
- John Kim, Public Health Agency of Canada, Canada

Talk 7. Community engagement in behavioural surveillance research (panel discussion) 
- David Brennan, University of Toronto, Canada
- Jeff Morgan, CBRC - Community Based Research Centre for Gay Men’s Health, Canada
- Lisa McDaid, University of Glasgow, UK

Talk 8. Application of theoretical models to periodic behavioural surveillance and what is missed if you do not have one (panel discussion) 
- Paul Flowers, Glasgow Caledonian University, UK
- Kiffer Card, Simon Fraser University, Canada

Speaker(s):

Rino Rappuoli, GSK Vaccines, Italy

Talk 1. Neurosyphilis is more common among malignant syphilis: Based on case series evidence 
- Pingyu Zhou, Shanghai Skin Disease Hospital, China

Talk 2. A case series of syphilis masquerading as thoracic malignancy
- Jessica Doctor, Guys' and St Thomas's NHS Foundation Trust, UK

Talk 3. Syphilis as fibromyalgia with unexplained hepatosplenomegaly
- Jackie Sherrard, Buckinghamshire Healthcare NHS Trust, UK

Speaker:

Bill Miller, Editor in Chief, Sexually Transmitted Diseases

Speaker(s):

Helena Seth-Smith, University Hospital Basel, Switzerland

Speaker(s):

Christina Marra, University of Washington, USA

Speaker(s):

Charlotte Loppie, University of Victoria, Canada

Talk 1. Must the evaluation of complex interventions be complex? Learning from the impact evaluation of DREAMS 
- Isolde Birdthistle, The London School of Hygiene & Tropical Medicine, UK 

Talk 2. HPTN 071 (PopART): Findings and lessons from a non-traditional RCT
- Richard Hayes, The London School of Hygiene & Tropical Medicine, UK

Talk 3. Using multiple data sources for programme evaluation: Integration of program monitoring data with other research studies
- Banadakoppa Ramesh, University of Manitoba, Canada

Talk 4. Evaluating complex public health issue violence - understanding and measuring violence and evaluating violence interventions - lessons from STRIVE
- Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute, South Africa

Talk 1. HIV self-testing in Eastern and Southern Africa: The STAR project
- Maryam Shahmanesh, London’s Global University, UK

Talk 2. Syphilis self-testing: A nationwide pragmatic study among men who have sex with men in China
- Cheng Wang, Southern Medical University, China

Talk 3. HPV self-collection in Peru: Project HOPE
- Patricia Garcia, Universidad Peruana Cayetano Heredi, Peru

Talk 4. Empowerment and approaches for stigma reduction: Implementation of HIV self-testing among female sex workers
- Catherine Oldenburg, University of California, USA

Talk 1. Impact of HIV PrEP on risk compensation and STI epidemiology – what does the evidence show?
- Helen Ward, Imperial College London, UK

Talk 2. The role of oral-anal transmission in persistence of chlamydial infection
- Henry de Vries, University of Amsterdam, Netherlands

Talk 3. Sexual transmission of N. meningitidis in MSM and implications for public health
- Anna McNulty, Sydney Sexual Health Centre, Australia

Talk 4. Hepatitis C in HIV-negative MSM – a growing concern?
- Axel J. Schmidt, London School of Hygiene and Tropical Medicine, UK

Talk 1. Resistance-guided therapy for M.genitalium: Impact of diagnostic resistance assays on practice and policy
- Catriona Bradshaw, Central Clinical School, Monash University, Australia

Talk 2. Point of care and home testing opportunities: Implications for quality public health practice
- Patricia Dittus, Centers for Disease Control and Prevention, USA

Talk 3. Home based testing: Unintended consequences and implications for antimicrobial stewardship – Should we be concerned?
- Paddy Horner, Population Health Sciences, University of Bristol, UK

Talk 4. Implementing molecular testing to predict Neisseria gonorrhoeae susceptibility in clinical practice
- Jeffrey D. Klausner, Fielding School of Public Health, US

Talk 1. Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine
- Henju Marjuki, Centers for Disease Control and Prevention, USA

Talk 2. Genetic, structural, and surface antigenic variation of Treponema pallidum’s OMPeome: Steps towards a global syphilis vaccine
- Kelly Hawley, Connecticut Children's Medical Center, USA

Talk 3. Engineering hybrid bacterial transferrin receptor-based vaccines to confer broad protection against Neisseria gonorrhoeae
- Scott Gray-Owen, University of Toronto, Canada

Talk 4. Rabbit immunization with B. burgdorferi expressing T. pallidum TprK and Tp0435 as a novel vaccine design for syphilis
- Lorenzo Giacani, University of Washington, USA

Talk 5. A meningococcal native outer membrane vesicle vaccine as a platform for presenting conserved gonococcal antigens
- Gregory Moe, UCSF Benioff Children's Hospital Oakland, USA

Talk 6. Meningococcal vesicle vaccines deleted for major outer membrane proteins enhance gonococcal clearance in a murine model
- Kathryn Matthias, US Food and Drug Administration, USA

Talk 1. What Is the optimal testing strategy for oropharyngeal Neisseria gonorrhoeae in women visiting STI clinics
- Christian Hoebe, Public Health Service South Limburg, Maastricht University Medical Center (MUMC+), The Netherlands

Talk 2. Oropharyngeal and genital gonorrhoea among heterosexuals who report sexual contact with partners with gonorrhoea
- Eric Chow, Alfred Health, Australia

Talk 3. Antimicrobial resistance in pharyngeal Neisseria gonorrhoeae infection: A cross-sectional study in men who have sex with men
- Hester Allen, Public Health England, UK

Talk 4. Incidence and duration of pharyngeal and rectal gonorrhea and chlamydia among high-risk men who have sex with men (MSM)
- Lindley Barbee, University of Washington, USA

Talk 5. Inflammatory cytokines in rectal gonorrhea/chlamydia infection and treatment: Towards STI control as HIV prevention for MSM
- Jesse Clark, UCLA Geffen School of Medicine, USA

Talk 6. Extragenital Mycoplasma genitalium infections amongst men who have sex with men
- Rosie Latimer, Monash University, Australia

Talk 1. Natural history of genital and oral herpes simplex virus-1 (HSV-1) shedding after first episode genital HSV-1 infection
- Christine Johnston, University of Washington, USA

Talk 2. Detection of glycosylated Treponema pallidum proteins: Relevance for diagnostic assays and importance for infection
- Alloysius Gomez, University of Victoria, Canada

Talk 3. The European gonococcal antimicrobial surveillance programme findings 2017
- Michaela Day, Public Health England, UK

Talk 4. Modelling intervention strategies for preventing spread of extensively drug resistant gonorrhoea strains among Australian MSM
- Qibin Duan, UNSW Sydney, Australia

Talk 5. Utility of real-time whole genome sequencing in partner notification and control of Neisseria gonorrhoeae infection
- Ling Yuan Kong, Leeds Teaching Hospitals NHS Trust, UK

Talk 6. Vaginal bacteria and risk of incident and persistent infection with high risk sub-types of human papillomavirus
- Kayla Carter, University of Washington, USA

Speaker(s):

Jørgen Jensen, Statens Serum Institut, Denmark

Speaker(s):

Tonia Poteat, University of North Carolina, USA

Speaker(s):

Geoff Garnett, Bill & Melinda Gates Foundation, USA

Talk 1. Working with community to control HIV/STI: A U.S. local health department perspective
- Matthew Golden, University of Washington, USA

Talk 2. Mobilising for health and rights: A history of sex worker activism in India
- Smarajit Jana, Sonagachi Research and Training Institute, India

Discussion on how communities can be mobilized and empowered to support HIV/STI control

Talk 1. Use of cervical explants to study gonococcal pathogenesis
- Daniel Stein, University of Maryland, USA

Talk 2. Bringing culture to the uncultured: Long-term culture of the syphilis spirochete, Treponema pallidum
- Steven Norris, University of Texas, USA

Talk 3. Pigtailed macaque model of STIs
- Dorothy Patton, University of Washington, USA

Talk 4. Chlamydia, trichomonas and syphilis infections in macaques: Effects on simian HIV acquisition
- Sundaram Ajay Vishwanathan, Center for Disease Control and Prevention, USA

Talk 1. The North American overdose crisis: How structural violence, prohibition, and stigma have paralyzed our response
- Mark Tyndall, BC Centre for Disease Control, Canada

Talk 2. Chemsex and new STI/HIV diagnoses among gay, bisexual and other men who have sex with men attending sexual health clinics
- Aseel Hegazi, St George's University Hospital Foundation Trust, UK

Talk 3. Challenges in defining Chemsex. Answers for surveillance from EMIS-2017
- Axel J. Schmidt, London School of Hygiene and Tropical Medicine, UK

Talk 4. Review of sexualized drug use associated with sexually transmitted infections (STI) in men who have sex with men (MSM)
- Fiona Guerra, Public Health Ontario, Canada

Talk 1. Novel pathway to ceftriaxone resistance in clinical isolates of N. gonorrhoeae via point mutations in the RNA polymerase
- Yonatan Grad, Harvard T.H. Chan School of Public Health, USA

Talk 2. Phylogenomic analysis reveals persistence of Neisseria gonorrhoeae clades with reduced susceptibility to cephalosporins
- Jesse Thomas, US Centers for Disease Control and Prevention, USA

Talk 3. Prioritizing novel drug targets based on genomics and proteomics approach in Neisseria gonorrhoeae
- Daman Saluja, University of Delhi, India

Talk 4. Mycoplasma genitalium parC and gyrA mutations associated with moxifloxacin and sitafloxacin treatment failure
- Gerald Murray, The Royal Women's Hospital, Australia

Talk 5. Point-of-care magnetofluidic assay cartridge for Neisseria gonorrhoeae detection and antimicrobial resistance determination
- Alexander Trick, Johns Hopkins University, USA

Talk 6. Prediction of available drug targets of Neisseria gonorrhoeae based on codon usage parameter
- Uma Chaudhry, Bhaskaracharya College of Applied Sciences, University of Delhi, India

Talk 1. Lower genital tract predictors of acute endometritis among women with signs and symptoms of pelvic inflammatory disease (PID)
- Sharon Hillier, University of Pittsburgh and Magee-Womens Research Institute, USA

Talk 2.Characterizing the impact of penile-vaginal sex on HIV-susceptible CD4+ T Cell subsets in the female genital tract
- Avid Mohammadi, University Of Toronto, Canada

Talk 3. The combined contraceptive vaginal ring increases Th17-related cytokines in the genital tract: A randomized crossover trial
- Iyaloo Konstantinus, University of Cape Town, South Africa

Talk 4. The effect of the combined oral contraceptive pill on the vaginal microbiota of women treated for bacterial vaginosis
- Larissa Ratten, Monash University, Australia

Talk 5. Cervicovaginal metabolic profiling reveals the interplay between HPV, microbiota and inflammation in cervical carcinogenesis
- Melissa Herbst-Kralovetz, University of Arizona, USA

Talk 1. Gentamicin for pharyngeal gonorrhea: A single-arm, non-blinded clinical trial
- Lindley Barbee, University of Washington, USA

Talk 2. In vitro combination testing and selection of resistance to zoliflodacin combined with six antimicrobials for N. gonorrhoeae
- Magnus Unemo, World Health Organization Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Sweden

Talk 3. Efficacy of resistance guided therapy for Mycoplasma genitalium using doxycycline followed by azithromycin or moxifloxacin
- Duygu Durukan, Alfred Health, Australia

Talk 4. Efficacy and cost-effectiveness of HPV vaccine with imiquimod or podophyllotoxin for patients with anogenital warts (HIPvac)
- Richard Gilson, University College London, UK

Talk 5. Do treatment rates suffer in a low-touch screening model? New York City sexual health clinics, 2017-2018
- Kelly Jamison, Centers for Disease Control and Prevention, USA

Talk 6. Reduction in adherence to antiretroviral therapy during postpartum: Findings from a prospective cohort study
- Anthony Ajayi, University of Fort Hare, South Africa

Talk 1. Multiple lineages of multiresistant shigella in Australia
- Deborah Williamson, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Australia

Talk 2. Use of whole-genome sequencing to identify sexual transmission of shigella in men who have sex with men in England
- Holly Mitchell, University College London, UK

Talk 3. Sexually transmissible enteric infections in men who have sex with men: Preliminary findings from a cross-sectional study
- Holly Mitchell, University College London, UK

Talk 4. Incidence of sexual behaviors and relationship to the urethral microbiota among men who have sex with men (MSM) in Seattle
- Laura Chambers, University of Washington, USA

Talk 5. The index case’s partnership status is important in predicting the likelihood of persistence of introduced XDR NG among MSM
- Ben Hui, UNSW Sydney, Australia

Talk 6.A RCT to facilitate psychosocial care among high risk MSM in Amsterdam, a SYNdemic BASed INtervention (Syn.bas.In Study)
- Roel Achterbergh, Public Health Service of Amsterdam, The Netherlands

Talk 1. Dequalinium chloride vaginal tablets for recalcitrant Trichomonas vaginalis (TV): A case report
- Deborah Goode, Leeds Teaching Hospitals Trust, UK

Talk 2. Penile intraepithelial neoplasia: Myriad presentations and intractablecourse
- Somesh Gupta, All India Instiute of Medical Sciences, India

Talk 3. Persisting urethritis in an immunocompromised patient
- William Geisler, University of Alabama at Birmingham, USA

Speaker:

Carolyn Deal, Chief, STD Branch, National Institute of Allergy and Infectious Disease, NIH

Speaker(s):

Wafaa El-Sadr, Columbia University, USA

Panel Speakers:

1. Journalism – Irin Carmon, Senior Correspondent, New York Magazine & CNN Contributor, USA

2. Academic Researcher - Dr. Rebecca Thurston, University of Pittsburgh, USA: MeToo and women’s health: Harassment, trauma, and midlife women’s cardiovascular health

The Plenary Panel “#MeToo Movement, Systems of Power and Sexual Health and Wellbeing: The Widening of the #MeToo Movement” will bring together expert speakers to discuss the impact and implications of the #MeToo movement for sexual health, social justice and equity.

Presentation: The MeToo Movement’s 2019 PSA Campaign
This panel will show the new campaign from the #Me Too Movement from creative agency Deutsch and #MeToo movement creator Tarana Burke. The videos focus on the dignity, humanity and healing of survivors of sexual violence. They feature firsthand accounts and reflections from four survivors of sexual violence and abuse, including Terry Crews. "In the year that's gone by, I've learned that silence is violence," says the "Brooklyn Nine-Nine" star in the video. "I will not be shamed. I did nothing wrong."

Aboriginal Health Elders Advisory Council at Vancouver Coastal Health
Yuúusnewas program at YouthCO HIV & Hep C Society

Speakers:
The idea for this symposium was developed through discussion with Elders from the Aboriginal Health Elders Advisory Council at Vancouver Coastal Health. This Council includes Elders from the Coast Salish peoples on whose land this conference is held, specifically the Sḵwx̱wú7mesh (Squamish), Sel̓íl̓witulh (Tsleil-Waututh), and xʷməθkʷəy̓əm (Musqueam) Nations, and from Nations from the Four Directions.
The Aboriginal Health Elders Advisory Council will be leading this symposium in partnership with the Yuúusnewas program at YouthCO HIV & Hep C Society. The Yuúusnewas program is an Indigenous youth-led program that centres Indigenous teachings in conversations about sexual health and harm reduction. Through workshops and cultural activities, this team of educators creates spaces for all Indigenous young people to develop solutions to the impacts of HIV and Hep C stigma on youth in what is now called British Columbia.

Support:
Organization of this symposium is supported by members of the Conference nə́c̓aʔmat ct Indigenous Sexual Health Committee. Financial support for this symposium is provided by the BC Centre for Disease Control, First Nations Health Authority, Indigenous Services Canada, and the Vancouver Foundation.

Talk 1. The relationship between demographics, health needs and the HIV care cascade outcomes: From infection to viral suppression
- Abigail Kroch, Ontario HIV Treatment Network (OHTN), Canada

Talk 2. Cascade of HIV prevention: A powerful tool to improve the implementation of DREAMS combination prevention in rural South Africa
- Maryam Shahmanesh, London’s Global University, UK

Talk 3. Application of a cascade approach for guiding prevention of congenital syphilis
- Patricia Garcia, Universidad Peruana Cayetano Heredia, Peru

Talk 4. Cascades and other approaches to guide PrEP programming
- Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute, South Africa

Talk 1. High rates of curable STIs in low and middle income countries
- Connie Celum, University of Washington, USA

Talk 2. Building STD clinical infrastructure in LMIC – Role of general vs. specialized infrastructure
- Ligang Yang, Southern Medical University, China 

Talk 3. Cervical cancer prevention in LMICS: Are we on the path to elimination?
- Megan Huchko, Duke University, USA

Talk 4. Self-care interventions for sexual and reproductive health and rights
- Manjulaa Narasimhan, World Health Organization, Switzerland

Talk 1. Introduction to the vaginal microbiome preconference symposium
- Jeanne Marrazzo, University of Alabama at Birmingham School of Medicine, USA

Talk 2. Lessons learned from the pre-meeting symposium on characterizing the vaginal microbiota through a blinded multi-laboratory collaboration
- Jen Balkus, University of Washington, USA

Talk 3. The vaginal microenvironment prior to incident STI
- Rebecca Brotman, University of Maryland School of Medicine, USA

Talk 4. Role of the genital tract microbiome in sexual and reproductive health: Report from the Keystone Symposium in Cape Town, 2018
- Janneke van de Wijgert, University of Liverpool, UK and University Medical Center Utrecht, The Netherlands

Talk 1. Pre-exposure prophylaxis in Brazil: Opportunities and challenges for men who have sex with men, Brazil, 2018
- Diego Calixto, Ministry of Health of Brazil, Brazil

Talk 2. Sexual behaviour, risk and sexually transmitted infections before and after the introduction of the PrEP impact trial
- Louis MacGregor, University of Bristol, UK

Talk 3. Rates of chlamydia and gonorrhea testing and positivity before and after initiation of PrEP among MSM in US private settings
- Guoyu Tao, Centers for Disease Control and Prevention, USA

Talk 4. Influence of HIV-status and PrEP use on high STI prevalences in MSM in Germany, 2018
- Klaus Jansen, Robert Koch Institute, Germany

Talk 5. Trends in bacterial STI incidence and impact of PrEP use among MSM attending Western Sydney sexual health centre (2013-2018)
- David Lewis, Western Sydney Local Health District, Australia

Talk 6. Frequency and determinants of switching between daily or event-driven PrEP and discontinuing each regimen in Amsterdam MSM
- Liza Coyer, Public Health Service of Amsterdam, The Netherlands

Talk 1. The Netherlands chlamydia cohort study: Pregnancies in women with and without a previous chlamydia infection
- Bernice Hoenderboom, National Institute for Public Health and the Environment, The Netherlands

Talk 2. Declines in chlamydia-associated PID at SSHS in England since 2007: What might this tell us about chlamydia control?
- Paddy Horner, University of Bristol, UK

Talk 3.Potential Neisseria gonorrhoeae outbreak in heterosexuals younger than 25 revealed three clusters by culture-free genotyping
- Brian Van Der Veer, Maastricht University Medical Center (MUMC+), The Netherlands

Talk 4. HIV and HCV among clients of female sex workers in Dnipro, Ukraine
- Marissa Becker, University of Manitoba, Canada

Talk 5. Hepatitis C incidence rate among people who inject drug (PWID) in British Columbia from 2000 to 2015
- Yiqiao Li, British Columbia Center for Disease Control, Canada

Talk 6. Development of an integrated data mart for surveillance of sexually transmitted and bloodborne infections (STIBBI)
- Jason Wong, BC Centre for Disease Control, Canada

Speaker(s):

Kevin Hybiske, University of Washington, USA

Speaker(s):

David Wilson, World Bank, USA

Speaker(s):

David Peters, Johns Hopkins University, USA

Talk 1. Progress towards a gonorrhea vaccine
- Kate Seib, Griffith University, Australia

Talk 2. A tri-antigen protective syphilis vaccine design that enhances treponemal clearance and inhibits pathogen dissemination
- Lorenzo Giacani, University of Washington, USA

Talk 3. Therapeutic vaccination to treat HPV disease: Lessons learned from high grade intraepithelial lesions
- Margaret Madeleine, Fred Hutchinson Cancer Research Center, USA

Talk 4. A mucosal Chlamydia trachomatis vaccine stimulates protective memory T cells
- Michael Starnbach, Harvard University, USA

Talk 1. Does azithromycin have a future in the treatment of gonorrhoea and chlamydial infection?
- Jane Hocking, University of Melbourne, Australia

Talk 2. Should enteric infections in MSM always be treated?
- Mark Pakianathan, St George’s University Hospital Foundation Trust, UK

Talk 3. Do rectal bacterial STIs in women matter? Who should we test and when?
- Christine Khosropour, University of Washington, USA

Talk 4. HPV vaccination in MSM: Who should be vaccinated and is there a role for vaccination of older and/or HIV-positive MSM in preventing initial, persistent and recurrent HPV and related diseases?
- David Templeton, University of Sydney, Australia

Talk 1. Sexual contact networks, STI transmission and the effectiveness of interventions: Insights from mathematical modelling
- Christian Althaus, University of Bern, Switzerland

Talk 2. Use of whole genome sequencing to explore transmission between sexual networks in an STI outbreak
- Helen Fifer, Public Health England, UK

Talk 3. Maximizing the acceptability, feasibility and validity of sexual network studies: Lessons from the field
- Abby Norris Turner, Ohio State University, USA

Talk 4. The role of sexual networks in the global spread of antimicrobial-resistance enteric infections
- Nigel Field, University College London, UK

Talk 1. HIV pre-exposure prophylaxis (PrEP) indications and uptake vary by race, gender and insurance in a large clinic network
- Maria Pyra, Howard Brown Health, USA

Talk 2. Impact of HIV-PrEP for female-sex-workers on community-wide awareness, uptake and perceptions in a rural-area Kwazulu-Natal
- Natsayi Chimbindi, Africa Health Research Institute (AHRI), South Africa

Talk 3. High curable STI prevalence and incidence among young African women initiating PrEP in HPTN 082
- Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa

Talk 4. Scaling up HCV screening and treatment for eliminating HCV among MSM in UK in the era of HIV pre-exposure prophylaxis
- Louis MacGregor, University of Bristol, UK

Talk 5. Patterns of HIV pre-exposure prophylaxis care one year after initiating PrEP, Baltimore City, Maryland 2015-2018
- Linxuan Wu, Johns Hopkins School of Medicine, USA

Talk 6. A longitudinal analysis of men who have sex with men’s condom use and attitudes during HIV antiretroviral prevention scale-up
- Nathan Lachowsky, University of Victoria, Canada

Talk 1. An update on the performance of STI services for gay and bisexual men across 40 cities: Preliminary results from EMIS-2017
- Jason Doran, London School of Hygiene and Tropical Medicine, Ireland

Talk 2. How do the sexual networks of men who have sex with men in one mid-Atlantic city differ by race/ethnicity?
- Jessica Wagner, Johns Hopkins University School of Medicine, USA

Talk 3. “You feel invisible”: A qualitative exploration of young LGBT+ people’s attitudes towards STI/HIV testing in primary care
- Lorraine McDonagh, University College London, UK

Talk 4. Trans & gender diverse people's experiences of sexual health care are associated with sexual health screening uptake
- Denton Callander, New York University, USA

Talk 5. Impact of HIV self-testing on the promotion of HIV testing among men who have sex with men in China: A randomized controlled trial
- Weibin Cheng, Dermatology Hospital of Southern Medical University, China

Talk 6. Trends in chlamydia screening and pap testing among US females by age and race; National Survey of Family Growth, 2006-2017
- Laura Haderxhanaj, Centers for Disease Control and Prevention, USA

Talk 1. Exploring relationship duration among gay and bisexual men: A longitudinal event-level analysis
- Kiffer Card, University of Victoria, Canada

Talk 2. Partnership context and consistent condom use among young African American men
- Megan Clare Craig-Kuhn, Tulane University School of Public Health and Tropical Medicine, USA

Talk 3. Epidemiological impact of expedited partner therapy for men who have sex with men: A modeling study
- Kevin Weiss, Emory University, USA

Talk 4. Effects of enhanced STI partner notification counselling in Cape Town: Randomized controlled trial
- Catherine Mathews, South African Medical Research Council, South Africa

Talk 5. Partner notification outcomes for chlamydia/gonorrhea cases diagnosed through clinics vs GetCheckedOnline in British Columbia
- Arina Zamanpour, British Columbia Centre for Disease Control, Canada

Talk 6. Contact tracing vs patient-delivered partner treatment for African American heterosexual men with chlamydia
- Patricia Kissinger, Tulane School of Public Health and Tropical Medicine, USA

Talk 1. Rapid PrEP reinitiation in a patient with ongoing risk
- Negusse Ocbamichael PA-C, STD Clinic/Public Health-Seattle & King County at Harborview, USA

Talk 2. Neonatal HSV: Could this transmission have been prevented?
- Elizabeth Foley, Solent NHS Trust, UK

Speakers:

Dennis Fortenberry, Director of Adolescent Medicine, Indiana University, USA

Caroline Cameron, University of Victoria, Canada

Speaker(s):

Johan Melendez, Johns Hopkins University, USA

Speaker(s):

Rena Janamnuaysook, The Thai Red Cross AIDS Research Centre, Thailand

Chair(s):

Kyle Bernstein, Centers for Disease Control and Prevention, USA

Speaker(s):

For the motion: Christopher Fairley, Monash University, Australia

Against the motion: Hunter Handsfield, University of Washington, USA

Talk 1. Four Treponema pallidum proteins detected in urine from syphilis-infected individuals using mass spectrometry
- Chris Kenyon, Institute of Tropical Medicine, Belgium

Talk 2. CRISPR diagnostics: Expanding the nucleic acid detection toolbox by harnessing microbial diversity
- Jonathan Gootenberg, Massachusetts Institute of Technology, USA

Talk 3. Reducing the global burden of infectious diseases through precision infection management (PIM)
- Ian Lewis, University of Calgary, Canada

Talk 4. Combatting HIV with nanomaterials
- Kim Woodrow, University of Washington, USA

Talk 1. Anatomical sites of infection: Biomedical considerations for STI prevention
- Jane Hocking, University of Melbourne, Australia

Talk 2. Modelling considerations related to multi-site infection
- Ian Spicknall, Centers for Disease Control and Prevention, USA

Talk 3. Anatomical sites of infection: Behavioural considerations for STI prevention
- Catherine Mercer, University College London, UK

Talk 4. Designing an approach to deal with extragenital sexually transmitted infections: Do we have the data we need?
- Jeanne Marrazzo, University of Alabama, USA

Talk 1. HPV screening – New evidence and current state of the art
- Suzanne Garland, The Royal Women’s Hospital, Australia

Talk 2. Treatment of Bacterial vaginosis: How, when and how much?
- Caroline Mitchell, Harvard University, USA

Talk 3. Screening women for bacterial STIs: Should we scale back?
- Jonathan Ross, University of Birmingham, UK

Talk 4. Prematurity and STI – value of screening and treatment
- Deborah Money, University of British Columbia, Canada

Talk 1. An update on the status of HIV/STIs in IUSTI's five regions
- John Kaldor, The Kirkby Institute, Sydney, Australia

Talk 2. Bridging the gap - best practice global examples of integration of HIV and STI services
- Janet Wilson, National Health Service, UK

Talk 3. Improving the sexual and reproductive health of women living with HIV
- Angelica Espinosa Miranda, Universidade Federal do Espirito Santo, Brazil

Talk 4. Engaging culturally and linguistically diverse populations in HIV/STI services: Challenges and opportunities
- Shailendra Sawleshwarkar, The University of Sydney, Australia

Talk 1. Factors associated with safer sex efficacy among Northern and indigenous youth in the Northwest Territories, Canada
- Carmen Logie, University of Toronto, Canada

Talk 2. Mixed methods analysis: Role of parents, peers and perceived severity of sexual health outcomes among Native American youth
- Lauren Tingey, Johns Hopkins University, USA

Talk 3. High prevalence of cervico-vaginal infections among female adolescents in four urban regions of Panama
- Amanda Gabster, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama

Talk 4. Patterns of drug use among MSM in Amsterdam and sexually transmitted infections, The Netherlands: A cluster analysis
- Roel Achterbergh, Public Health Service of Amsterdam, The Netherlands

Talk 5. Reaching home-based female sex workers with preventive sexual health care services in The Netherlands
- Charlotte Peters, South Limburg Public Health Services, The Netherlands

Talk 6. Precarious legal immigration status linked to client condom refusal among sex workers in Metro Vancouver (2010-2018)
- Bronwyn McBride, Centre for Gender and Sexual Health Equity, Canada

Talk 1. Optimizing screening for chlamydia: Is there a role for screening heterosexual men?
- Minttu Rönn, Harvard T.H. Chan School of Public Health, USA

Talk 2. Can community Chlamydia trachomatis screening of young heterosexual men help identify infected networks?
- Patricia Kissinger, Tulane School of Public Health and Tropical Medicine, USA

Talk 3. Disparities in access to HIV point-of-care testing: The non-urban Canadian context
- Jacqueline Gahagan, Dalhousie University, Canada

Talk 4. Implementation of point of care gonorrhea and chlamydia testing in an STD clinic PrEP program, San Francisco, 2017-2018
- Stephanie Cohen, San Francisco Department of Public Health, USA

Talk 5. Chlamydia trachomatis testing: A national evaluation of internet based self-sampling in Sweden
- Björn Herrmann, Uppsala University Hospital, Sweden

Talk 6. mAfrica: Zenzele, a mobile-phone enabled HIV testing and linkage to care pathway for young people in rural South Africa
- Maryam Shahmanesh, University College London, UK

Talk 1. “A PrEP user is someone who has a lot of bareback”: A qualitative study of acceptability of PrEP in MSM in Lebanon
- Ismael Maatouk, Clemenceau Medical Center, Lebanon

Talk 2. Interested? Why or why not? STI clinic client perceptions of bacterial STI vaccines in British Columbia, Canada
- Kara Plotnikoff, University of British Columbia, Canada

Talk 3. Development of a scale measuring stigma towards alcohol abstinence among people living with HIV in Vietnam
- Kathryn Lancaster, The Ohio State University, USA

Talk 4. Predictors of incorrect HIV care initiation beliefs among people living with HIV/AIDS in Chókwè District, Mozambique
- Christine Hara, Public Health Institute, Mozambique

Talk 5. Syphilis risk perceptions among repeatedly infected men who have sex with men in Beirut, Lebanon
- Ismael Maatouk, Clemenceau Medical Center, Lebanon

Talk 6. Women’s approaches to involving others in making HIV trial enrollment decisions while pregnant in the US and Malawi
- Kristen Sullivan, University of North Carolina at Chapel Hill, USA

Talk 1. Perspectives from North America
- Karen Schlanger, Center for Disease Control and Prevention, USA

Talk 2. Perspectives from Brazil and Latin America
- Adele Schwartz Benzaken, Tropical Medicine Foundation, Manaus, Amazonas, Brazil

Talk 3. Perspectives from Thailand
- Pachara Sirivongrangson, Thailand Ministry of Public Health, Thailand

Talk 4. Public health approaches to gonorrhea prevention and the threat of antibiotic resistance – perspectives from Europe
- Otilia Mårdh, European Centre for Disease Prevention and Control (ECDC), Sweden

Talk 1. Understanding how laws and policies affect HIV prevention practices: A theoretical approach
- Morten Skovdal, University of Copenhagen, Denmark

Talk 2. Intersectionality, criminalisation and sexual health
- Carmen Logie, University of Toronto, Canada

Talk 3. The health impacts of sex work criminalization: A review of the evidence 
- Lucy Platt, The London School of Hygiene & Tropical Medicine, UK 

Talk 4. Criminalisation of HIV transmission in the era of U=U 
- Michael Brady, Kings College Hospital/Terrence Higgins Trust, UK

Talk 1. Youth and community based research
- Sarah Flicker, York University, Canada

Talk 2. Addressing anti-LGBT stigma and medical mistrust through a data-informed approach to community engagement
- Errol Fields, Johns Hopkins University, USA

Talk 3. Authentic and successful community engagement for STI/HIV prevention, screening, and treatment in rural and urban settings
- Scott Rhodes, Wake Forest School of Medicine, USA

Talk 4. Spurring innovation in improving community engagement for STI prevention
- Weiming Tang, University of North Carolina Project-China, China

Talk 1. Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation
- Shin Ohira, Kawasaki Medical School, Japan

Talk 2. Mapping regions of host attachment in the T. pallidum adhesin Tp0751; Function-informed vaccine design
- Sean Waugh, University of Victoria, Canada

Talk 3. Cytokine immune response against natural human papillomavirus infection among men in Kisumu, Kenya
- Raphael Ondondo, Masinde Muliro University of Science and Technology, Kenya

Talk 4. Structural similarity of Treponema pallidum protein Tp0225 with human toll-like receptor 2
- Simon Houston, University of Victoria, Canada

Talk 5. Targeting complement receptor 3 on primary human cervical cells has the potential to cure Neisseria gonorrhoeae infection
- Jennifer Edwards, The Research Institute at Nationwide Children's Hospital and The Ohio State University, USA

Talk 6. Basic science aids syphilis vaccine development: Bloodstream spreading by the syphilis spirochete Treponema pallidum
- Karen Lithgow, University of Victoria, Canada

Talk 1. HPV FOCAL 48 month exit results by age for women HPV or LBC negative at baseline screening
- Gina Ogilvie, University of British Columbia, Canada

Talk 2. Women's experiences with primary human papillomavirus (HPV) testing for cervix screening: HPV FOCAL exit survey results
- Laurie Smith, BC Cancer, Canada

Talk 3. Declining rates of cervical intraepithelial neopleasia after introduction of the HPV vaccine in British Columbia, Canada
- Robine Donken, BC Children’s Research Institute, Canada

Talk 4. Impact of the human papillomavirus immunization program on rates of anogenital warts in British Columbia, Canada 2000-2017
- Christine Lukac, University of British Columbia, Canada

Talk 5. Declining trends in anogenital warts since HPV vaccine introduction in a large urban health system, 2013-2017
- Linda Niccolai, Yale School of Public Health, USA

Talk 6. Parents'/healthcare providers' knowledge, attitude and perception of school-based HPV vaccination program in Lagos, Nigeria
- Adebola Adejimi, College of Medicine, University of Lagos, Nigeria

Talk 1. Prevalence of active syphilis among transwomen in São Paulo, Brazil
- Beatriz Paiatto, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Brazil

Talk 2. Estimating disease burden of maternal syphilis and associated adverse pregnancy outcomes in China
- Yajie Wang, Dermatology Hospital of Southern Medical University, China

Talk 3. Development of a syphilis serum repository for research and evaluation of syphilis diagnostics tests in the United States
- Mayur Shukla, Centers for Disease Control and Prevention, USA

Talk 4. Evaluation of routinized syphilis screening with HIV viral loads among men living with HIV
- Ann Burchell, St. Michael's Hospital, Canada

Talk 5. HIV seropositivity and early syphilis stage predictive of ocular syphilis diagnosis in British Columbia, Canada: 2010-2018
- Hasan Hamze, University Of British Columbia, Canada

Talk 6. Prenatal care entry among pregnant women with syphilis who use methamphetamines: A key to congenital syphilis prevention
- Rosalyn Plotzker, California Department of Public Health, USA

Talk 1. Model-based study design for estimation of route-specific gonorrheal transmission probabilities
- Ethan Romero-Severson, Los Alamos National Laboratory, USA

Talk 2. Bridging of Neisseria gonorrhoeae across diverse sexual networks in the HIV PrEP era
- Deborah Williamson, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Australia

Talk 3. Partner services for gonorrhea can decrease new HIV among MSM in King County, Washington: A mathematical modeling study
- Gui Liu, University of Washington, USA

Talk 4. Molecular epidemiology of HIV among foreign-born residents of King County, Washington, USA; Using HIV surveillance data
- Diana Tordoff, University of Washington, USA

Talk 5. The influence of risk group turnover in STI/HIV epidemics: Mechanistic insights from transmission modeling
- Jesse Knight, St. Michael's Hospital, Canada

Talk 6. Professional injectors, injection networks, and HIV: Case studies from five cities in Pakistan
- Laura Thompson, University of Manitoba, Canada

Speaker(s):

Charlotte Watts, UK Department of International Development (DFID), UK